Alfuzosin HCL
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
SPE2D218R0029
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
This solicitation, identified by procurement number SPE2D218R0029 and titled "Alfuzosin HCL," was issued by DLA Troop Support, a federal office responsible for providing critical supplies to military and federal agencies. The procurement falls under NAICS code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further classified under Product Service Code 6505, indicating a focus on pharmaceutical products.
The primary objective of this procurement is the supply of Alfuzosin HCL, a pharmaceutical product used in the treatment of certain medical conditions. The contract has undergone several modifications, as indicated by the referenced amendments (P00001 through P00004) to contract SPE2D2-19-D-0068. These modifications primarily relate to the exercise of contract options, extending the performance period in one-year increments, and the incorporation of specific Federal Acquisition Regulation (FAR) clauses—namely FAR 52.204-4 and FAR 52.204-25—into the contract. The most recent option period invoked covers March 18, 2022, through March 17, 2023.
The intended outcome of this procurement is to ensure a reliable and continuous supply of Alfuzosin HCL to meet the needs of the contracting agency. Contractors are expected to deliver pharmaceutical-grade Alfuzosin HCL in accordance with all applicable federal standards and contract requirements. The scope of work likely includes manufacturing, packaging, and timely delivery of the product, although specific quantities and delivery schedules are not detailed in the provided information.
DLA Troop Support serves as the contracting entity, with Phyllis Daraio listed as the primary point of contact for this solicitation. She can be reached via email at [email protected] or by phone at 215-737-7941 for any inquiries related to this opportunity.
This procurement was posted on February 3, 2022, but is currently marked as inactive, with a response date that has already passed (December 8, 2018). The solicitation was originally posted on SAM.gov, where additional attachments related to the opportunity are available for review.
There is no information provided regarding set-aside requirements, special considerations, or specific deliverable quantities. Contractors interested in similar future opportunities should ensure they are capable of meeting federal pharmaceutical manufacturing standards and are familiar with the relevant FAR clauses incorporated into such contracts.
In summary, this procurement sought qualified suppliers for the ongoing provision of Alfuzosin HCL, with contract performance managed through annual option periods and compliance with federal acquisition regulations. The opportunity was managed by DLA Troop Support, and all communications were directed to the designated contracting officer.
Documents6